The recent clinical successes of cancer immunotherapy (PD-1/PD-L1 immune checkpoint blockade and chimeric antigen receptor T cell therapy) are attracting considerable interest in harnessing the immune system to fight cancer [1–4]. Here, CD274 is linked to cancer.